Benzinga

DECEMBER 20, 2022

JMP has raised the price target from $182 to $312 and reiterates its Market Outperform rating. Resmetirom looks approvable based on Phase 3 MAESTRO-NASH data, the analyst said. The analyst raised POS for resmetirom to 90% in both the U.S. billion (compared to $3 billion and ~$600.

Marketability 98

Marketability 98

Benzinga

OCTOBER 5, 2022

NASDAQ: TWTR ) for the originally agreed price of $44 billion. The Twitter Ananlyst: To give effect to the development, Wedbush analyst Daniel Ives raised his price target for the Twitter stock from $50 to $54.20. The analyst maintained his Neutral rating on the shares. The Twitter Thesis: Tesla Inc.

98

98

Benzinga

FEBRUARY 21, 2024

Shares of VIZIO Holding (NYSE: VZIO ) closed lower on Wednesday amid a series of downgrades from Wall Street analysts. JPMorgan downgraded the stock to Neutral, while raising their price target to $11.50 Craig-Hallum downgraded Vizio stock to Hold Roth MKM downgraded the stock to Neutral, lowering their price target to $11.50

52

52

Benzinga

OCTOBER 21, 2022

The Analyst: Michael Feniger upgraded the rating for GFL Environmental from Neutral to Buy, while reducing the price target from $34. Full story available on Benzinga.com.

97

97

Benzinga

JANUARY 18, 2024

The Tempur Sealy International Analyst: Peter Keith upgraded the rating for Tempur Sealy International from Neutral to Overweight, while raising the price target from $41 to $61. The Tempur Sealy International Thesis: The company is likely to. Full story available on Benzinga.com

52

52

Benzinga

JUNE 28, 2022

While FTX CEO and co-founder Sam Bankman-Fried put the rumors to rest for now, one analyst can’t help but think of the possibility of a merger. The Robinhood Analyst: Piper Sandler analyst Richard Repetto has a Neutral rating on Robinhood and a price target of $11. The company’s zero.

Marketability 98

Marketability 98

Benzinga

JULY 8, 2022

(NYSE: TWTR ) shareholders in the summer to approve the take-private deal, an analyst at Wedbush said he sees a "greater looming uncertainty" surrounding the completion of the transaction. The Twitter Analyst: Daniel Ives maintained a Neutral rating on Twitter shares and reduced the price target from $54 to $43.

98

98

Benzinga

JULY 18, 2023

Needham analyst Anna Andreeva reiterated a Buy rating on the shares of Etsy Inc (NASDAQ: ETSY ) with a price target of $130. Today ETSY announced the sale of its Brazilian marketplace Elo7 without disclosing any terms of the deal. ETSY acquired Elo in June 2021 for $217 million.

Equity 52

Equity Marketability 52

Benzinga

AUGUST 30, 2022

Here’s what one analyst has to say about the newest piece of information in the highly publicized acquisition of the social media platform. The Twitter Analyst: Wedbush analyst Daniel Ives has a Neutral rating on Twitter and $50 price target. Full story available on Benzinga.com.

98

98

Benzinga

AUGUST 1, 2023

Several analysts reacted to the company's performance and acquisition. KeyBanc analyst Justin Patterson maintained an Overweight rating on DoubleVerify with a $45 price target. Stifel analyst Mark Kelley reiterated a Buy rating with a price target of $44.

EBITDA 52

EBITDA Technology 52

Benzinga

JUNE 16, 2023

BMO Capital Markets analyst Ketan Mamtora raised the price target of Beacon Roofing Supply Inc (NASDAQ: BECN ) to $90 from $75, maintaining an Outperform rating. The analyst has confidence in BECN's medium-term growth, margin expansion initiatives, and capability to cruise through tough economic conditions.

Marketability 52

Marketability Equity 52

Benzinga

FEBRUARY 2, 2023

The Okta Analyst: Alex Henderson upgraded the rating for Okta from Hold to Buy, while establishing a price target of $90. Check out other analyst stock ratings. Management’s revenue growth guidance of 16%-17% appears conservative, according to Needham. The Okta Thesis: Although the.

52

52

Benzinga

AUGUST 8, 2023

Many analysts raised the price target of KKR & Co Inc (NYSE: KKR ) following the Q2 FY23 results and acquisition deal reported yesterday. Maintaining the Buy rating, Deutsche Bank boosted the price. Revenues of $3.63 billion came significantly higher than $323.4 billion in an all-cash deal.

Banking 52

Banking Equity Marketability 52

Benzinga

OCTOBER 13, 2023

Canaccord Genuity analyst David Hynes Jr reiterated a Buy rating on Atlassian Corp (NASDAQ: TEAM ) with a price target of $230. Atlassian announced an agreement to acquire Loom , a video messaging platform, for $880 million in cash and $95 million in vesting equity.

Equity 59

Equity 59

Benzinga

MARCH 13, 2024

Mizuho Securities analyst Nitin Kumar downgraded EQT Corporation (NYSE: EQT ) to Neutral from Buy and cut the price target to $39 from $46. The rating downgrade reflects the company’s FY23 reserves, 2024 guidance, and the proposed merger with Equitrans Midstream Corporation (NYSE: ETRN ).

Enterprise Value 52

Enterprise Value Equity 52

Benzinga

AUGUST 16, 2022

’s (NASDAQ: SGEN ) stock may offer a nearer-term opportunity, but the biotech's position as an attractive strategic target is “too intriguing to ignore.” ” That's according to RBC Capital Markets analyst Gregory Renza who named Merck & Co. NYSE: MRK ) as a fitting buyer.

Marketability 59

Marketability 59

Benzinga

MAY 16, 2022

The Analyst. Pablo Zuanic , from Cantor Fitzgerald , rated Columbia Care Inc. OTC: CCHWF ) as Overweight with a price target of $5.10. However, Zuanic will keep the rating, estimates and price target unchanged on shares of CCHWF until the company has filed SEDAR statements for the quarter. The Thesis.

Marketability 98

Marketability 98

Benzinga

SEPTEMBER 22, 2023

BMO Capital Markets On Splunk Analyst Keith Bachman downgraded the rating from Outperform to Market Perform, while raising the price target from $127 to $157. “The deal is expected to close by the third quarter of Calendar Year 2024,” the analyst stated.

Enterprise Value 52

Enterprise Value Marketability 52

Benzinga

FEBRUARY 23, 2024

The Zoom Video Analyst: JPMorgan analyst Mark R. Murphy rates the stock Neutral with a price target of $83. This implies an upside of 33.69% from a price of $62.12 It is set to report fourth-quarter earnings on Feb. 26 (after market hours), with the Street expecting $1.15 in EPS and $1.11 billion in revenue.

Marketability 52

Marketability 52

Benzinga

OCTOBER 4, 2022

Here's why one Twitter analyst is saying the news isn't too surprising. The Twitter Analyst: Wedbush analyst Daniel Ives has a Neutral rating on Twitter with a $50 price target. The analyst’s price target is “Musk deal dependent.”

52

52

Benzinga

OCTOBER 17, 2022

NYSE: WFC ) analyst Michael Blum initiated coverage of Archaea Energy Inc. NYSE: LFG ) with an Overweight rating and a price target of $25 per share. Blum, turns out, touts an accuracy rating of 75%, according to Benzinga’s Analysts Ratings Calendar. 4, Wells Fargo & Co.

Net Debt 52

Net Debt Marketability 52

Benzinga

MARCH 9, 2023

UBS analyst Manav Gupta initiated coverage of Marathon Petroleum Corp (NYSE: MPC ) with a Buy rating and price target of $165. Gupta's report comes on the heels of Marathon's acquiring a 49.9% stake in renewable natural gas producer LF Bioenergy for $50 million. billion to shareholders.

97

97

Harvard Corporate Governance

MARCH 21, 2023

To bring insider trading cases in the absence of a federal statute targeting insider trading, prosecutors have adapted various more general statutes, including the anti-fraud prohibitions in Section 10(b) of the Securities Exchange Act and Rule 10b-5 promulgated thereunder and, increasingly, a potpourri of other federal statutes.

245

245

Benzinga

DECEMBER 13, 2022

The Analyst: Chris Shibutani upgraded the rating for Pfizer from Neutral to Buy, while raising the price target from $47 to $60. The company’s product pipeline and new launches offset the COVID-19 uncertainty in 2023, according to Goldman Sachs. The Thesis: The New. Full story available on Benzinga.com.

52

52

Benzinga

APRIL 5, 2022

The AMD Analyst: KeyBanc Capital Markets analyst John Vinh maintained an Overweight rating and $165 price target for AMD shares. The AMD Thesis: KeyBanc is constructive on the Pensando deal, analyst Vinh said in a note. It also strives to reduce total cost of ownership, he added.

Marketability 94

Marketability 94

Benzinga

JUNE 10, 2022

A merger of Spirit Airlines Incorporated (NYSE: SAVE ) is “a high probability outcome,” and a merger with JetBlue Airways Corporation (NASDAQ: JBLU ) is more likely than with Frontier (NASDAQ: ULCC ), according to a JPMorgan analyst.

52

52

Benzinga

FEBRUARY 9, 2024

JPMorgan Chase analyst Bill Peterson maintained a Neutral rating on Piedmont Lithium Inc. NASDAQ: PLL ) and lowered his price target from $25 to $15. million) to A$325 million (~$214 million), and the final price of the offer is set at A$17.00 (~$11.18) per CHESS depository interest.

52

52

Benzinga

SEPTEMBER 26, 2023

DA Davidson analyst Tom Forte maintained a Buy rating and price target of $150. RBC Capital Markets analyst Brad Erickson said the deal “should be good for faster test/learn around AWS infrastructure.” ” and. Full story available on Benzinga.com

Marketability 59

Marketability 59

Benzinga

SEPTEMBER 22, 2022

Raymond James reiterates a Strong Buy rating on UnitedHealth Group Inc (NYSE: UNH ) while raising the price target to $635 from $620 as a U.S. judge gave a green signal for Change Healthcare Inc's (NASDAQ: CHNG ) acquisition. The ruling ended a 21-month fight between UnitedHealth and regulators.

52

52

Benzinga

JUNE 14, 2022

Benchmark analyst Robert Wasserman downgraded AeroClean Technologies Inc (NASDAQ: AERC ) to Hold from Buy , without a price target. The analyst notes that despite a poor overall market outlook, the company's shares have quickly reached and exceeded earlier price targets.

Technology 52

Technology Marketability 52

Benzinga

NOVEMBER 28, 2022

Third quarter earnings season is slowly wrapping up and analysts are tweaking their ratings accordingly. Cantor Fitzgerald analyst Pablo Zuanic kicked off the week by taking a closer look at two cannabis stocks. Auxly Cannabis Group Inc (OTC: CBWTF ). Net loss climbed to $CA60.1 million , compared to CA13.53

EBITDA 52

EBITDA Marketability 52

Benzinga

JUNE 9, 2022

An analyst at KeyBanc Capital Markets, however, does not see the deal materializing. The Roku, Netflix Analyst: Justin Patterson has a Sector Weight rating on Netflix. The analyst rates Roku an Overweight, with a $160 price target. This, according to the analyst, suggests the. NASDAQ: NFLX ).

Marketability 52

Marketability 52

Benzinga

SEPTEMBER 21, 2022

The Analyst: Michael McGovern maintained an Underperform rating for Lyft, with the price target unchanged at $14. The Thesis: Although the San Francisco-based company is a takeover target for “autonomous vehicle developers and OEMs” and. Full story available on Benzinga.com.

Banking 52

Banking 52

Benzinga

OCTOBER 12, 2022

The Analyst: Daniel Ives upgraded the rating for DocuSign from Underperform to Neutral, while maintaining the price target at $55. The Thesis: The stock has lost around 50% since early May, and the San Francisco-based company could become an acquisition target by a financial or strategic player.

52

52

Benzinga

NOVEMBER 29, 2022

The analyst retained an "Overweight" rating on the company's stock while keeping his price target of $15. . 's (TSX: XLY) (OTCQX: CBWTF ) and Columbia Care Inc. 's 's (OTCQX: CCHWF ) quarterly performance reports. Cresco Labs Inc (OTCMKTS: CRLBF).

Marketability 98

Marketability 98

Sun Acquisitions

OCTOBER 13, 2023

Valuation lies at the heart of every successful M&A transaction, providing a framework to determine the worth of a target company. By comparing key financial metrics such as price-to-earnings (P/E) ratios, price-to-sales (P/S) ratios, and price-to-book (P/B) ratios, analysts can estimate the target company’s value.

Discounted Cash Flow 59

Discounted Cash Flow Book Value Liquidation Value Price to Book 59

Benzinga

JULY 12, 2023

Wedbush Securities On Microsoft Corporation Wedbush Securities analyst Daniel Ives maintained an Outperform rating and a $375 price target.

52

52